Deutsche Bank upgraded Netflix to 'Buy' from 'Hold,' citing compelling share prices despite lowering its price target to $95 from $100 due to reduced operating income and free cash flow estimates following the second quarter earnings report.
Bank of America maintained its 'Buy' rating on Apple, arguing that concerns regarding Muse are overstated and that Apple will ultimately benefit from advancements in AI. Citi reiterated its 'Buy' rating on Nvidia, praising the company's recent buyback announcement, which signals confidence in strong AI-driven free cash flow growth.
TD Cowen and CLSA both initiated coverage on SpaceX with 'Buy' ratings, highlighting the company's potential in AI and space, particularly its terrestrial AI compute leasing expected to drive significant revenue growth by 2027. Bernstein initiated coverage on AutoZone with an 'Outperform' rating, indicating optimism about its growth potential.
Stifel upgraded Staar Surgical to 'Buy,' seeing an attractive entry point for investors. Wells Fargo upgraded Main Street Capital to 'Overweight,' citing strong earnings prospects. Melius upgraded Kroger to 'Buy,' noting a favorable disconnect between its earnings growth and valuation.
JPMorgan upgraded Bloomin' Brands to 'Neutral' after a positive meeting with management but downgraded PepsiCo to 'Neutral' due to concerns over underperformance in North America. Goldman Sachs reinstated Baker Hughes as 'Buy' with a price target of $71, while Oppenheimer initiated coverage on FuelCell Energy with an 'Outperform' rating.
Evercore ISI initiated Butterfly Network as 'Outperform,' emphasizing its large market potential. Lastly, JPMorgan initiated coverage on AbCellera with an 'Overweight' rating, projecting significant upside, and Goldman Sachs initiated Adaptive Biotechnologies as 'Buy,' forecasting a 23% upside based on its leadership in next-generation sequencing